Cybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.
Tanja Eisenblätter
Advertisement
Articles by Tanja Eisenblätter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
2
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
The Industry's Interest in Vaccine Platforms
5